XML 28 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating activities      
Net earnings $ 15,242 $ 23,144 $ 20,639
Noncash items:      
Depreciation and amortization 4,099 3,972 3,400
Deferred income taxes (296) (245) (673)
Share-based compensation 1,018 1,059 925
Loss on sale of subsidiary and subsidiaries held for sale 8,310 0 0
Gains on dispositions and other strategic transactions (3,333) (489) (588)
Other, net (28) (16) 257
Net change in other operating items, net of effects from acquisitions and dispositions:      
Accounts receivable (1,437) (3,114) (2,523)
Other assets (4,140) (2,444) (1,374)
Medical costs payable 2,503 3,482 4,053
Accounts payable and other liabilities 2,463 3,516 1,964
Unearned revenues (197) 203 126
Cash flows from operating activities 24,204 29,068 26,206
Investing activities      
Purchases of investments (27,308) (18,314) (18,825)
Sales of investments 18,514 7,307 5,907
Maturities of investments 9,319 9,230 6,081
Cash paid for acquisitions and other transactions, net of cash assumed (13,408) (10,136) (21,458)
Purchases of property, equipment and capitalized software (3,499) (3,386) (2,802)
Loans to care providers - cyberattack (9,033) 0 0
Repayments of care provider loans - cyberattack 4,514 0 0
Cash received from dispositions and other strategic transactions, net 2,041 685 3,414
Other, net (1,667) (960) (793)
Cash flows used for investing activities (20,527) (15,574) (28,476)
Financing activities      
Common share repurchases (9,000) (8,000) (7,000)
Cash dividends paid (7,533) (6,761) (5,991)
Proceeds from common stock issuances 1,846 1,353 1,253
Repayments of long-term debt (3,000) (2,125) (3,015)
(Repayments of) proceeds from short-term borrowings, net (151) 11 732
Proceeds from issuance of long-term debt 17,811 6,394 14,819
Customer funds administered (1,560) (521) 5,548
Purchases of redeemable noncontrolling interests (280) (730) (176)
Other, net (1,645) (1,150) (1,944)
Cash flows (used for) from financing activities (3,512) (11,529) 4,226
Effect of exchange rate changes on cash and cash equivalents (61) 97 34
Increase in cash and cash equivalents, including cash within businesses held for sale 104 2,062 1,990
Less: cash within businesses held for sale (219) 0 0
Net (decrease) increase in cash and cash equivalents (115) 2,062 1,990
Cash and cash equivalents, beginning of period 25,427 23,365 21,375
Cash and cash equivalents, end of period 25,312 25,427 23,365
Supplemental cash flow disclosures      
Cash paid for interest 3,594 3,035 1,945
Cash paid for income taxes $ 4,620 $ 6,078 $ 5,222